Millennium Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-493,633
| Closed | -$47.9M | – | 4866 |
|
|
2019
Q3 | $47.9M | Sell |
493,633
-169,216
| -26% | -$16.9M | 0.08% | 321 |
|
|
2019
Q2 | $67.9M | Sell |
662,849
-31
| -0% | -$3.35K | 0.1% | 217 |
|
|
2019
Q1 | $75.5M | Buy |
+662,880
| New | +$48.7M | 0.11% | 213 |
|
|
2018
Q4 | – | Sell |
-72,538
| Closed | -$3.96M | – | 4420 |
|
|
2018
Q3 | $3.96M | Sell |
72,538
-28,595
| -28% | -$1.96M | ﹤0.01% | 1973 |
|
|
2018
Q2 | $8.37M | Buy |
101,133
+77,434
| +327% | +$5.98M | 0.01% | 1443 |
|
|
2018
Q1 | $1.58M | Buy |
+23,699
| New | +$1.37M | ﹤0.01% | 2457 |
|
|
2017
Q4 | – | Sell |
-242,952
| Closed | -$21.7M | – | 4238 |
|
|
2017
Q3 | $21.7M | Sell |
242,952
-292,679
| -55% | -$22.2M | 0.03% | 752 |
|
|
2017
Q2 | $32M | Buy |
535,631
+92,638
| +21% | +$5.18M | 0.06% | 482 |
|
|
2017
Q1 | $23.6M | Sell |
442,993
-573,633
| -56% | -$34.1M | 0.04% | 590 |
|
|
2016
Q4 | $50.7M | Buy |
+1,016,626
| New | +$54.5M | 0.11% | 257 |
|
|
2016
Q3 | – | Sell |
-310,809
| Closed | -$15.9M | – | 3773 |
|
|
2016
Q2 | $15.9M | Buy |
310,809
+270,909
| +679% | +$11.6M | 0.04% | 635 |
|
|
2016
Q1 | $1.18M | Buy |
39,900
+21,044
| +112% | +$664K | ﹤0.01% | 2097 |
|
|
2015
Q4 | $854K | Buy |
+18,856
| New | +$988K | ﹤0.01% | 2378 |
|
|
2015
Q3 | – | Sell |
-147,320
| Closed | -$8.88M | – | 3877 |
|
|
2015
Q2 | $8.88M | Buy |
+147,320
| New | +$9.74M | 0.02% | 1053 |
|
Millennium Management's ONCE Position: Q4 2019 in Review
Millennium Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 493,633 shares — an estimated $47.9M sold.
Millennium Management first reported a position in ONCE in Q2 2015 and held it in 14 quarters. The position peaked at $75.5M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- Millennium Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- Millennium Management sold 493,633 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $47.9M.
- Millennium Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2015 and held it in 14 quarters.
- Millennium Management's Spark Therapeutics, Inc. Common Stock position peaked at $75.5M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.